Bapsi Chakravarthy

7PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 14, 2025
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163.

Nabil F Saba, Yael Flamand, Derrick T Lin

|Apr 26, 2021
Safety considerations with new treatment regimens for anal cancer.

Sarah K Cimino, Kristen K Ciombor, A Bapsi Chakravarthy

|Mar 13, 2020
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors.

Johanna M Schafer, Brian D Lehmann, Paula I Gonzalez-Ericsson

|Apr 25, 2019
National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.

Thomas J George, Aaron J Franke, A Bapsi Chakravarthy

|Jul 22, 2017
IL-6 variant is associated with metastasis in breast cancer patients.

Chike O Abana, Brian S Bingham, Ju Hwan Cho

Pageof 2